1,2,4-Oxadiazolidinones as configurationally stable chiral building blocks

Angewandte Chemie - International Edition

Volumn 44, Issue 6, 2005, Pages 936-938

  Ritter, Tobias ^a   Carreira, Erick M ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Asymmetric synthesis; Cycloaddition; Heterocycles; Isocyanates; Nitrones

Indexed keywords

DRUG PRODUCTS; PURIFICATION; STRUCTURE (COMPOSITION);

DRUG DEVELOPMENT; HETEROCYCLES; PURIFICATION PROTOCOLS;

ORGANIC ACIDS;

1,2,4 OXADIAZOLE DERIVATIVE; 1,2,4 OXADIAZOLIDINONE DERIVATIVE; HETEROCYCLIC COMPOUND; ISOCYANIC ACID DERIVATIVE; LINEZOLID; NITRONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; CYCLOADDITION; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; STRUCTURE ANALYSIS;

MOLECULAR STRUCTURE; OXAZOLES; STEREOISOMERISM;

EID: 13744262312     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200461934     Document Type: Article

References (19)

1. For a review on linezolid, see M. R. Barbachyn, C. W. Ford, Angew. Chem. 2003, 115, 2056; Angew. Chem. Int. Ed. 2003, 42, 2010.
2. For a review on linezolid, see M. R. Barbachyn, C. W. Ford, Angew. Chem. 2003, 115, 2056; Angew. Chem. Int. Ed. 2003, 42, 2010.
3. A related chiral heterocyclic core can be found in HIV protease inhibitors, see G. V. De Lucca, P. Y. S. Lam, Drugs Future 1998, 23, 987.
4. For application as microbiocides, see: Merck Patent Gesellschaft mit beschränkter Haftung (DE), US 6455529 B1, 2002;
5. b) For application as adhesion receptor antagonists see: Du Pont Merck Pharma (US), US 5610294, 1997;
6. c) For application as retroviral protease inhibitors, see: Syngenta Crop Protection, US2004/0063937, 2004.
7. a) H. Goldschmidt, Ber. Dtsch. Chem. Ges. 1890, 23, 2746;
8. b) E. Beckmann, Ber. Dtsch. Chem. Ges. 1890, 23, 3319;
9. c) A. M. T. Bell, J. Bridges, R. Cross, C. P. Falshaw, B. F. Taylor, G. A. Taylor, I. C. Whittaker, M. J. Begley, J. Chem. Soc. Perkin Trans. 1 1987, 2593;
10. d) For a review on nitrone cycloadditions including isocyanates as reaction partners, see: D. S. C. Black, R. F. Crozier, V. C. Davis, Synthesis 1975, 7, 205.
11. In a study of asymmetric cycloaddition involving nitrones and olefins, brief mention of the cycloaddition reaction with phenyl-isocyanate is described. At best a 2:1 ratio of diastereomers was obtained, and attempts to remove the phenethyl auxiliary led to destruction of the heterocycle, see: C. Belzecki, I. Panfil, J. Chem. Soc. Chem. Commun. 1977, 303.
12. D. Blaser, D. Seebach, Liebigs Ann. Chem. 1991, 1067.
13. S. W. Baldwin, A. Long, Org. Lett. 2004, 6, 1653.
14. R. Fitzi, D. Seebach, Tetrahedron 1988, 44, 5277.
15. R. Fässler, D. E. Frantz, J. Oetiker, E. M. Carreira, Angew. Chem. 2002, 114, 3180; Angew. Chem. Int. Ed. 2002, 41, 3054.
16. R. Fässler, D. E. Frantz, J. Oetiker, E. M. Carreira, Angew. Chem. 2002, 114, 3180; Angew. Chem. Int. Ed. 2002, 41, 3054.
17. For the development of the chiral mannose-derived nitrones, see: A. Vasella, Helv. Chim. Acta 1977, 60, 1273.
18. A. Basha, R. Henry, M. A. McLaughlin, J. D. Ratajczyk, S. J. Wittenberger, J. Org. Chem. 1994, 59, 6103.
19. a as ≤2 for the corresponding conjugate acid.